Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) Short Interest Update

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) was the recipient of a large growth in short interest in the month of February. As of February 27th, there was short interest totaling 214,975 shares, a growth of 17.8% from the February 12th total of 182,496 shares. Based on an average daily trading volume, of 35,157 shares, the days-to-cover ratio is presently 6.1 days. Based on an average daily trading volume, of 35,157 shares, the days-to-cover ratio is presently 6.1 days.

Neonc Technologies Price Performance

Shares of NASDAQ NTHI traded down $0.11 during mid-day trading on Tuesday, hitting $8.86. The stock had a trading volume of 17,026 shares, compared to its average volume of 56,277. The company has a 50 day moving average of $9.44 and a two-hundred day moving average of $9.42. Neonc Technologies has a twelve month low of $3.20 and a twelve month high of $25.00.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NTHI. HighPoint Advisor Group LLC raised its holdings in Neonc Technologies by 424.8% in the 3rd quarter. HighPoint Advisor Group LLC now owns 950,232 shares of the company’s stock worth $8,628,000 after purchasing an additional 769,163 shares during the period. Bank of America Corp DE purchased a new position in Neonc Technologies in the 2nd quarter valued at $801,000. Vanguard Group Inc. purchased a new position in shares of Neonc Technologies in the third quarter worth about $1,279,000. 683 Capital Management LLC acquired a new position in shares of Neonc Technologies during the 4th quarter worth approximately $442,000. Finally, Global Retirement Partners LLC acquired a new position in Neonc Technologies during the third quarter worth $434,000.

Analyst Ratings Changes

A number of analysts recently commented on the company. Weiss Ratings reissued a “sell (e+)” rating on shares of Neonc Technologies in a report on Monday, December 29th. Zacks Research upgraded shares of Neonc Technologies to a “hold” rating in a research note on Wednesday, January 14th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Reduce”.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.